Parkinson's disease represents a major burden affecting over 1% of people aged over 60. With no cure available to date to slow down or stop disease progression, current treatment options mostly focus on improving the motor symptoms and patients' quality of life.

What if there were a way to accurately spot the signs of Parkinson's disease very early on, even before the onset of visible symptoms?

Which hallmarks do characterize Parkinson's disease and do any relevant, quantitative and clinically relevant biomarker exist?

In this webinar, you will learn (and get a refresh) about the main pathophysiological straits of Parkinson's disease, mechanistically wise, understand the link between cortical network oscillatory disturbances and the onset of motor symptoms, and lastly get insights about the next therapeutic strategies at stake to address the various forms of Parkinson's disease in a more efficient way.